Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral propranolol for retinopathy of prematurity
IRCT20100520003982N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of propranolol in retinopathy of prematurity (ROP) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Improvement in retinopathy, Need for laser therapy and 4 more. Started Jul 2017; status: completed.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT20100520003982N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100520003982N1.